-
www.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-145-materials-v-a.pdf
June 25, 2014 - Cardiovascular monitor
ing and stimulant drugs for attention
deficit/hyperactivity disorder.
-
www.ahrq.gov/sites/default/files/wysiwyg/ecareplan/reports/ecare-plan-for-mcc-v2.pdf
January 01, 2025 - enable standardized transfer of
data across health and research settings for kidney disease, diabetes, cardiovascular
-
effectivehealthcare.ahrq.gov/sites/default/files/back-pain-treatment_disposition-comments.pdf
February 29, 2016 - based examinations, screenings,
evaluations, and interventions for
musculoskeletal, neurological,
cardiovascular
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/patient-monitoring-systems-rapid-review.pdf
December 01, 2024 - condition was associated with a
significantly higher likelihood of patients with an alert receiving cardiovascular
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2022-surv-rep-3-tables-F1-4.xlsx
January 01, 2022 - lower gastrointestinal, mood, urogenital, upper gastrointestinal, airways, ear-nose-throat, dermal, cardiovascular
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/jmCXJwxefa67VY4NfD8gUg
June 26, 2018 - Raloxifene and
cardiovascular events in osteoporotic
postmenopausal women: four-year results from the
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/insulin-blood-sugar-2010_executive.pdf
January 01, 2010 - Intensive diabetes
treatment and cardiovascular disease in patients with type
1 diabetes.
-
www.ahrq.gov/sites/default/files/wysiwyg/research/findings/nhqrdr/2023-NHQDR-appendixes-ACDE.pdf
January 01, 2023 - • From 2000 to 2021, 83% of cancer measures, 43% of cardiovascular disease measures, 20%
of chronic
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/tech-brief-31-mobile-applications-self-mgmt.pdf
May 01, 2018 - Director of Diabetes and Cardiovascular
Disease
Prevention
American Medical Association
Chicago,
-
effectivehealthcare.ahrq.gov/sites/default/files/tech-brief-37-opiod-use-adults-comments.pdf
November 03, 2020 - neurological damage, can aggravate my MS
symptoms, cause hypertension and increase the
rate that cardiovascular
-
www.ahrq.gov/sites/default/files/wysiwyg/professionals/education/continuing-ed/moc_sms.pdf
March 29, 2016 - Interventions to promote physical activity and dietary lifestyle changes for cardiovascular risk factor
-
www.ahrq.gov/sites/default/files/wysiwyg/chsp/compendium/2018-Compendium-TechDoc-update.pdf
January 01, 2018 - xxvi The Medicare models that we excluded include the Million Hearts Cardiovascular Disease Reduction
-
www.ahrq.gov/sites/default/files/wysiwyg/research/findings/nhqrdr/2023-NHQDR-appendixes-ACDE-rev.pdf
January 01, 2023 - • From 2000 to 2021, 83% of cancer measures, 43% of cardiovascular disease measures, 20%
of chronic
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/alcohol-misuse_disposition-comments.pdf
July 10, 2012 - often confusion in clinical practice between
recommendations to drink moderate amounts to prevent
cardiovascular
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2023-surv-rep-1-app-F.xlsx
January 01, 2023 - lower gastrointestinal, mood, urogenital, upper gastrointestinal, airways, ear-nose-throat, dermal, cardiovascular
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2023-surv-rep-4-tables-E-1-E-4.xlsx
January 01, 2023 - lower gastrointestinal, mood, urogenital, upper gastrointestinal, airways, ear-nose-throat, dermal, cardiovascular
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2022-surv-rep-4-tables-F1-4.xlsx
January 01, 2022 - lower gastrointestinal, mood, urogenital, upper gastrointestinal, airways, ear-nose-throat, dermal, cardiovascular
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-2024-surv-rep-update-tables-e1-4.xlsx
January 01, 2024 - lower gastrointestinal, mood, urogenital, upper gastrointestinal, airways, ear-nose-throat, dermal, cardiovascular
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/TYPA75a_t7HaJeDhWqCJ9n
August 13, 2019 - No study measured
effects of treatment on long-term quality of life, cardiovascular out-
comes, or mortality
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-2025-surv-rep-update-tables-e1-4.xlsx
January 01, 2025 - lower gastrointestinal, mood, urogenital, upper gastrointestinal, airways, ear-nose-throat, dermal, cardiovascular